Evaluation of nucleolin and somatostatin receptor targeting for therapeutic delivery to lung cancer stem cells

Pernille Lund Hansen, Sif Holmboe, Birgitte Brinkmann Olsen, Helge Thisgaard, Helle Christiansen, Steffen Schmidt, Ines Block, Carolin Müller, Niels Langkjær, Per Trolle Jørgensen, Stefan Vogel, Jesper Wengel, Poul Flemming Høilund-Carlsen, Jan Mollenhauer

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato27. jun. 2016
StatusUdgivet - 27. jun. 2016
Begivenhed9th European & Global Summit for Cutting‐Edge Medicine: Clinical Nanomedicine and Targeted medicine - Basel, Schweiz
Varighed: 26. jun. 201629. jun. 2016
Konferencens nummer: 9

Konference

Konference9th European & Global Summit for Cutting‐Edge Medicine
Nummer9
LandSchweiz
ByBasel
Periode26/06/201629/06/2016

Citer dette

Hansen, P. L., Holmboe, S., Olsen, B. B., Thisgaard, H., Christiansen, H., Schmidt, S., ... Mollenhauer, J. (2016). Evaluation of nucleolin and somatostatin receptor targeting for therapeutic delivery to lung cancer stem cells. Poster session præsenteret på 9th European & Global Summit for Cutting‐Edge Medicine, Basel, Schweiz.
Hansen, Pernille Lund ; Holmboe, Sif ; Olsen, Birgitte Brinkmann ; Thisgaard, Helge ; Christiansen, Helle ; Schmidt, Steffen ; Block, Ines ; Müller, Carolin ; Langkjær, Niels ; Jørgensen, Per Trolle ; Vogel, Stefan ; Wengel, Jesper ; Høilund-Carlsen, Poul Flemming ; Mollenhauer, Jan. / Evaluation of nucleolin and somatostatin receptor targeting for therapeutic delivery to lung cancer stem cells. Poster session præsenteret på 9th European & Global Summit for Cutting‐Edge Medicine, Basel, Schweiz.
@conference{0f1e83b2f2174a3799d621bfb02badba,
title = "Evaluation of nucleolin and somatostatin receptor targeting for therapeutic delivery to lung cancer stem cells",
author = "Hansen, {Pernille Lund} and Sif Holmboe and Olsen, {Birgitte Brinkmann} and Helge Thisgaard and Helle Christiansen and Steffen Schmidt and Ines Block and Carolin M{\"u}ller and Niels Langkj{\ae}r and J{\o}rgensen, {Per Trolle} and Stefan Vogel and Jesper Wengel and H{\o}ilund-Carlsen, {Poul Flemming} and Jan Mollenhauer",
year = "2016",
month = "6",
day = "27",
language = "English",
note = "null ; Conference date: 26-06-2016 Through 29-06-2016",

}

Hansen, PL, Holmboe, S, Olsen, BB, Thisgaard, H, Christiansen, H, Schmidt, S, Block, I, Müller, C, Langkjær, N, Jørgensen, PT, Vogel, S, Wengel, J, Høilund-Carlsen, PF & Mollenhauer, J 2016, 'Evaluation of nucleolin and somatostatin receptor targeting for therapeutic delivery to lung cancer stem cells' 9th European & Global Summit for Cutting‐Edge Medicine, Basel, Schweiz, 26/06/2016 - 29/06/2016, .

Evaluation of nucleolin and somatostatin receptor targeting for therapeutic delivery to lung cancer stem cells. / Hansen, Pernille Lund; Holmboe, Sif; Olsen, Birgitte Brinkmann; Thisgaard, Helge; Christiansen, Helle; Schmidt, Steffen; Block, Ines; Müller, Carolin ; Langkjær, Niels ; Jørgensen, Per Trolle; Vogel, Stefan; Wengel, Jesper; Høilund-Carlsen, Poul Flemming; Mollenhauer, Jan.

2016. Poster session præsenteret på 9th European & Global Summit for Cutting‐Edge Medicine, Basel, Schweiz.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

TY - CONF

T1 - Evaluation of nucleolin and somatostatin receptor targeting for therapeutic delivery to lung cancer stem cells

AU - Hansen, Pernille Lund

AU - Holmboe, Sif

AU - Olsen, Birgitte Brinkmann

AU - Thisgaard, Helge

AU - Christiansen, Helle

AU - Schmidt, Steffen

AU - Block, Ines

AU - Müller, Carolin

AU - Langkjær, Niels

AU - Jørgensen, Per Trolle

AU - Vogel, Stefan

AU - Wengel, Jesper

AU - Høilund-Carlsen, Poul Flemming

AU - Mollenhauer, Jan

PY - 2016/6/27

Y1 - 2016/6/27

M3 - Poster

ER -

Hansen PL, Holmboe S, Olsen BB, Thisgaard H, Christiansen H, Schmidt S et al. Evaluation of nucleolin and somatostatin receptor targeting for therapeutic delivery to lung cancer stem cells. 2016. Poster session præsenteret på 9th European & Global Summit for Cutting‐Edge Medicine, Basel, Schweiz.